BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 8894629)

  • 1. Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course.
    Ben-David Y; Hallak M; Rotschild A; Sorokin Y; Auslender R; Abramovici H
    Fetal Diagn Ther; 1996; 11(5):341-4. PubMed ID: 8894629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin for the treatment of polyhydramnios: a case of constriction of the ductus arteriosus.
    Mohen D; Newnham JP; D'Orsogna L
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):243-6. PubMed ID: 1445137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prenatal diagnosis of premature closure of the ductus arteriosus with subsequent development of a non-immunologic hydrops fetalis].
    Chaoui R; Hoffmann H; Bollmann R; Wauer R
    Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1096-8. PubMed ID: 2693191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus.
    Moise KJ; Huhta JC; Sharif DS; Ou CN; Kirshon B; Wasserstrum N; Cano L
    N Engl J Med; 1988 Aug; 319(6):327-31. PubMed ID: 3393194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin and corticosteroids: an additive constrictive effect on the fetal ductus arteriosus.
    Levy R; Matitiau A; Ben Arie A; Milman D; Or Y; Hagay Z
    Am J Perinatol; 1999; 16(8):379-83. PubMed ID: 10772195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In utero congestive heart failure due to maternal indomethacin treatment for polyhydramnios and premature labour in a fetus with antenatal closure of the foramen ovale.
    Achiron R; Lipitz S; Kidron D; Berant M; Hegesh J; Rotstein Z
    Prenat Diagn; 1996 Jul; 16(7):652-6. PubMed ID: 8843476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study.
    Räsänen J; Jouppila P
    Am J Obstet Gynecol; 1995 Jul; 173(1):20-5. PubMed ID: 7631682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin in pregnancy: applications and safety.
    Abou-Ghannam G; Usta IM; Nassar AH
    Am J Perinatol; 2012 Mar; 29(3):175-86. PubMed ID: 21786219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of constriction of the fetal ductus arteriosus by Doppler echocardiography.
    Huhta JC; Moise KJ; Fisher DJ; Sharif DS; Wasserstrum N; Martin C
    Circulation; 1987 Feb; 75(2):406-12. PubMed ID: 3802445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible fetal hydrops associated with indomethacin use.
    Pratt L; Digiosia J; Swenson JN; Trampe B; Martin CB
    Obstet Gynecol; 1997 Oct; 90(4 Pt 2):676-8. PubMed ID: 11770593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study.
    Eronen M; Pesonen E; Kurki T; Ylikorkala O; Hallman M
    Am J Obstet Gynecol; 1991 Jan; 164(1 Pt 1):141-6. PubMed ID: 1986601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of indomethacin on the fetal ductus arteriosus during treatment of symptomatic polyhydramnios.
    Kirshon B; Mari G; Moise KJ; Wasserstrum N
    J Reprod Med; 1990 May; 35(5):529-32. PubMed ID: 2191133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doppler assessment of the renal blood flow velocity waveform during indomethacin therapy for preterm labor and polyhydramnios.
    Mari G; Moise KJ; Deter RL; Kirshon B; Carpenter RJ
    Obstet Gynecol; 1990 Feb; 75(2):199-201. PubMed ID: 2405319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin for preterm labor: fetal toxicity in a dizygotic twin gestation.
    Hallak M; Reiter AA; Ayres NA; Moise KJ
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):911-3. PubMed ID: 1923225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin.
    Shehata BM; Bare JB; Denton TD; Habib MN; Black JO
    Fetal Pediatr Pathol; 2006; 25(3):151-7. PubMed ID: 17060191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of prolonged indomethacin therapy.
    Savage AH; Anderson BL; Simhan HN
    Am J Perinatol; 2007 Apr; 24(4):207-13. PubMed ID: 17447185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age.
    Vermillion ST; Scardo JA; Lashus AG; Wiles HB
    Am J Obstet Gynecol; 1997 Aug; 177(2):256-9; discussion 259-61. PubMed ID: 9290437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus.
    Van den Veyver IB; Moise KJ; Ou CN; Carpenter RJ
    Obstet Gynecol; 1993 Oct; 82(4 Pt 1):500-3. PubMed ID: 8377971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premature closure of the ductus arteriosus causing intra-uterine death. A case report.
    Truter PJ; Franszen S; van der Merwe JV; Coetzee MJ
    S Afr Med J; 1986 Oct; 70(9):557-8. PubMed ID: 3775605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure.
    Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B
    J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.